73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Active surveillance OK for non-muscle invasive bladder cancer

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U

Active surveillance OK for non-muscle invasive bladder cancer

(HealthDay)—For patients with non-muscle invasive bladder cancer, active surveillance seems reasonable and cost-effective, according to a study published in the February issue ofThe Journal of U
Study: Cannabis use disorder increasing among veterans with psychiatric disorders

Study: Cannabis use disorder increasing among veterans with psychiatric disorders

by American Psychiatric AssociationCredit: Pixabay/CC0 Public DomainResearch publishedinThe American Journal of Psychiatryfinds that during a period of increasing cannabis use i

Study: Cannabis use disorder increasing among veterans with psychiatric disorders

by American Psychiatric AssociationCredit: Pixabay/CC0 Public DomainResearch publishedinThe American Journal of Psychiatryfinds that during a period of increasing cannabis use i
Researchers develop 'on-demand' whole tumor cell vaccine against cancer

Researchers develop 'on-demand' whole tumor cell vaccine against cancer

by Chinese Academy of SciencesStrategy of using photothermal nanoparticle-based whole tumor cell vaccine (LN-TCV) for on-demand near-infrared (NIR) manipulation of immune responses against cancer

Researchers develop 'on-demand' whole tumor cell vaccine against cancer

by Chinese Academy of SciencesStrategy of using photothermal nanoparticle-based whole tumor cell vaccine (LN-TCV) for on-demand near-infrared (NIR) manipulation of immune responses against cancer
Mechanism of a breast cancer drug points to a possible new therapy

Mechanism of a breast cancer drug points to a possible new therapy

by Sarah Avery,Duke UniversityThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom

Mechanism of a breast cancer drug points to a possible new therapy

by Sarah Avery,Duke UniversityThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom
Study: Immunotherapy costs drive increase in Medicare spending for outpatient cancer care at the end of life

Study: Immunotherapy costs drive increase in Medicare spending for outpatient cancer care at the end of life

by American Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients' lives

Study: Immunotherapy costs drive increase in Medicare spending for outpatient cancer care at the end of life

by American Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients' lives
Researchers identify a process responsible for therapeutic resistance in breast cancer

Researchers identify a process responsible for therapeutic resistance in breast cancer

by McGill UniversityMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at the Lady Davis Institute have identified a key protein that is

Researchers identify a process responsible for therapeutic resistance in breast cancer

by McGill UniversityMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainResearchers at the Lady Davis Institute have identified a key protein that is
Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according
Researchers find link between obesity and blood cancer

Researchers find link between obesity and blood cancer

by Jackie Maupin,Indiana University School of MedicineCredit: Unsplash/CC0 Public DomainIndiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential

Researchers find link between obesity and blood cancer

by Jackie Maupin,Indiana University School of MedicineCredit: Unsplash/CC0 Public DomainIndiana University School of Medicine researchers studying clonal hematopoiesis of indeterminate potential
Engineered receptors help the immune system home in on cancer

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af

Engineered receptors help the immune system home in on cancer

byUniversity of California, San FranciscoCredit: CC0 Public DomainMost cancer treatments—from chemotherapies to engineered immune cells—have a host of side effects, in large part because they af
Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainNovel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnose

Over half of English patients with NSCLC in areas with low socio-economic levels do not receive anti-cancer therapies

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainNovel anti-cancer therapies were not accessible to more than half of the patients in England who were diagnose
Study explores why patients skip appointments for suspected cancer

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect

Study explores why patients skip appointments for suspected cancer

by Shelley Hughes,University of YorkCredit: CC0 Public DomainMen, the elderly and people from deprived areas are among the patients most likely to miss an urgent referral appointment for suspect
T-cell interactions vary between tumor microenvironments

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar

T-cell interactions vary between tumor microenvironments

by Melissa Rohman,Northwestern UniversityShown is a p-STAT3- non-reactive astrocyte (white arrow) in close proximity to a CD3+p-STAT3- T cell (blue arrow) and a CD163+p-STAT3- macrophage (red ar